The VAGA Group has launched a new website – VAGARIGHTS.com. The site is being superseded by VAGA.org, which previously published all of the biohacking publication’s reviews, articles, and news. Vagarights.com is operated by Brian Johnson who remains the editor of VAGA.org.
VAGA, the biotechnology company and biohacking publication, has launched a new website: vagarights.com. The site will publish supplementary reports, biohacking articles, and the latest news from the world of biotechnology and biohacking. As with VAGA.org, vagarights.com will primarily focus on specific areas of biohacking including: neurohacking and nootropics, probiotics and microbiome engineering, immune system modulation, and longevity research. The website will publish in-depth supplement reviews on the latest and most popular nootropics, probiotics, prebiotics, omega-3 capsules, multivitamins, and green powders on the market.
VAGARIGHTS.com was created to allow VAGA.org to focus on more popular articles aimed at those new to biohacking, as well as biotechnology content of general interest. VAGARIGHTS.com, on the other hand, will focus almost entirely on reviews of supplements and news of biotechnology advances.
Brian Johnson, editor and lead author of most VAGA content, said the new site will help VAGA deliver better content to its readers. He said, “Vagarights.com will allow us to provide much wider and in-depth reviews of the latest biohacking supplements while providing our readers with the kind of readable, fun, and engaging content they demand.”
VAGARIGHTS is based in New York. The biotechnology company can be reached at 111 Broadway # 1006, New York, NY 10006, USA. Alternatively, you can reach editor Brian Johnson at firstname.lastname@example.org. Press inquiries should be directed to email@example.com.